The risk factors associated with CIC recurrence included early irAE development, long duration of the initial CIC, initial application of immunosuppressants, pneumonitis, hepatitis, age over 65, advanced tumor stage, CTLA-4 inhibitors use (227), and less antibiotic therapy (205, 224). This evidence concerns the gene CTLA4 and neoplasm.